Visit WTR Logo
Subscribe now

Litigation

English courts will thrive in life sciences patent litigation alongside the UPC

Rather than being overshadowed by the new pan-EU system, the UK will remain a crucial venue for pharma and biotech disputes

English courts will thrive in life sciences patent litigation alongside the UPC
Genentech’s troubles highlight biosimilar trade secret risks
23 Jul 2021

Genentech’s troubles highlight biosimilar trade secret risks

Two founders of JHL Biotech have recently been indicted for conspiracy to steal trade secrets from the Californian company, while two other individuals pleaded guilty to similar charges

Sisvel ties-up Oppo deal after multi-jurisdictional patent dispute settles
23 Jul 2021

Sisvel ties-up Oppo deal after multi-jurisdictional patent dispute settles

Pair bring to an end litigation that spanned three continents and also involved rights owned by Mitsubishi Electric

Latest

View all
22 Jul 2021

Australian pharma patentees must remain vigilant on third-party damages

Recent decisions have calmed concerns about a surge of lawsuits against patentees by third parties, but a significant risk remains Read more

21 Jul 2021

Has TCL become the latest Ericsson licensing sign-up?

The two companies settled long-running patent litigation in the same week as the Swedish company’s CEO and CFO announced a new, unnamed licensee Read more

20 Jul 2021

With the UK out of the picture, the UPC needs a local division based in Ireland

A common law tradition, close links to the US and native English language capabilities mean a Dublin-based court would greatly improve the pan-EU court’s attractions Read more

19 Jul 2021

Apple's threat to leave UK market over SEP dispute should not be dismissed as a bluff

In FRAND dust-up with Optis, the iPhone maker has raised the stakes and that could end with the British government getting involved Read more

News

View all
17 Jul 2021

The Arthrex fix is no fix at all

Neither SCOTUS nor the USPTO has come up with a workable solution to the issues at the heart of the case Read more

14 Jul 2021

Arthrex could offer life sciences patents extra layer of protection

Co-published - An additional level of scrutiny for IPR decisions will be a boon for owners of valuable pharma and biotech patents Read more

30 Jun 2021

The 2021 edition of the IAM Patent 1000 goes live

Definitive guide to the world’s leading private practice firms and individuals now available Read more

28 May 2021

For patent plaintiffs, Germany is the world’s top jurisdiction, exclusive IAM survey finds

The country beats the US into second place, but defendants say American courts are the best place to be Read more

Analysis

View all
19 Jul 2021

Singapore banking on regional IP rise and dispute resolution to cement its hub status

An update to the country’s strategy recognises that facilitating ASEAN's patenting development is key Read more

16 Jul 2021

Ericsson sees IP licensing income leap in wake of Samsung deal

Q2 results and overall trading outlook underline the importance of patent royalty revenues for the Swedish company Read more

15 Jul 2021

China’s patent linkage system is finally up and running

What the final implementing measures of the Hatch-Waxman-style framework mean for biopharma patentees and generics Read more

14 Jul 2021

Maxell’s latest deal shows the Japanese business is doubling down on its patent monetisation efforts

The operating company has added to portfolio for first time since embarking on litigation push against Apple and others Read more

Insights

View all
4 Nov 2020

Supreme Court could signal time’s up for Google’s anti-competitive IP infringement

A long-running battle with Oracle once again shines the spotlight on a pattern of alleged major IP infringements by the search giant Read more

12 Aug 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in May, June and July Read more

8 Jun 2020

IP Market news highlights

IAM’s biggest spring reads Read more

8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

Trending

1

Arthrex could offer life sciences patents extra layer of protection

2

The Arthrex fix is no fix at all

3

Apple's threat to leave UK market over SEP dispute should not be dismissed as a bluff

4

Biden Administration executive order makes Europe even more important for SEP owners

5

Ericsson sees IP licensing income leap in wake of Samsung deal

Find an expert

Tamir Packin
Partner
New York NY, United States
Desmarais LLP
View full biography